- 询价
- MedChemExpress(MCE)
- 美国
- HY-143315
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- 规格：
询盘
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Protease-Activated Receptor-1 antagonist 3
MCE 国际站：Protease-Activated Receptor-1 antagonist 3
产品活性：Protease-Activated Receptor-1 antagonist 3 是一种有效的 蛋白酶激活受体 1 protease-activated receptor-1 拮抗剂，IC50 值为 7 nM。Protease-Activated Receptor-1 antagonist 3 显示与 hERG K+ 通道的结合亲和力，IC50 值为 9 µM。
研究领域：GPCR/G Protein
作用靶点：Protease Activated Receptor (PAR)
In Vivo: Protease-Activated Receptor-1 antagonist 3 (compound 23) (3 mg/kg; i.v.) shows 10% bioavailability in rats.
相关产品：Vorapaxar | TRAP-6 | AZ3451 | SLIGRL-NH2 | PAR-4 Agonist Peptide, amide TFA | Trypsin | 2-Furoyl-LIGRLO-amide | GB-88 | SCH79797 | Protease-Activated Receptor-2, amide | GB-110 hydrochloride | FSLLRY-NH2 TFA | Parmodulin 2 | BMS-986120 | AC-55541 | I-191 | PZ-128 | AZ8838 | ENMD-1068 hydrochloride | Atopaxar | TFLLR-NH2(TFA) | PAR-2-IN-1 | VKGILS-NH2 | PAR-4 Agonist Peptide, amide | Protease-Activated Receptor-4 | tcY-NH2 TFA | Protease-Activated Receptor-1, PAR-1 Agonist TFA
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Chemokine Receptor Antagonist Development
This chapter describes assays that focus on the characterization of compounds identified in high-�throughput screening campaigns, and the subsequent medicinal chemistry programs. They cover methods to determine potency
Developing a Photoreactive Antagonist
approach for developing small molecules that, upon irradiation with light, may be used to rapidly inactivate targeted proteins expressed on the surfaces of cells. Highlighted is ANQX, a photoreactive AMPA receptor antagonist developed to irreversibly
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
than clopidogrel without an unacceptable increase in hemorrhagic or other side effects. Prasugrel (CS-747; LY-640315), a novel third-generation oral thienopyridine, is a specific, irreversible antagonist of the platelet ADP P2Y12 receptor. Pre-clinical and early
技术资料暂无技术资料 索取技术资料
